Skip to main content
Allison Kaeding, MD, Pediatric Hematology & Oncology, Seattle, WA

AllisonJuneKaedingMD

Pediatric Hematology & Oncology Seattle, WA

Pediatric Hematologic Oncology

Acting Instructor, Pediatric Blood & Marrow Transplantation, University of Washington/Seattle Cancer Care Alliance

Dr. Kaeding is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kaeding's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Pediatric Hematology/Oncology, 2015 - 2018
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 2012 - 2015
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2012

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2015 - 2025

Publications & Presentations

PubMed

Abstracts/Posters

  • Mesothelin Targeting Bites for Pediatric AML: In Vivo Efficacy and Specificity
    Allison Kaeding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic Strategies
    Allison Kaeding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • In Vivo Evaluation of Mesothelin As a Therapeutic Target in Pediatric Acute Myeloid Leukemia
    Allison Kaeding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018